DIFFERENT PROFILES OF THE HUMAN IMMUNE-RESPONSE TO PRIMARY AND SECONDARY IMMUNIZATION WITH AN ORAL SALMONELLA-TYPHI TY21A VACCINE

被引:46
|
作者
KANTELE, A
MAKELA, PH
机构
[1] National Public Health Institute
关键词
SALMONELLA-TYPHI TY21A; ANTIBODY-SECRETING CELLS; PRIMARY IMMUNIZATION; SECONDARY IMMUNIZATION; ORAL VACCINE; IMMUNOLOGICAL MEMORY; ELISPOT;
D O I
10.1016/0264-410X(91)90129-T
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human immune response to a secondary immunization by the oral route was studied by enumerating specific antibody-secreting cells (ASC) in the peripheral blood, believed to reflect the local immune response in the mucosa. The volunteers had been immunized 1-2 years earlier with live Salmonella typhi Ty21a given orally as three doses of vaccine in enteric-coated capsules (3 x E); their ASC and serum antibody responses have been published. In the present study 17 of the same volunteers received one booster dose of the same vaccine (B-E). Specific ASC appeared in the blood of all volunteers after vaccination, peaked on day 5 and faded away thereafter so that on day 9 specific ASC were detected in only seven subjects. The ASC responses to the single booster dose were significantly higher than those to one dose in primary immunization and at least as high as those of the same volunteers to three doses in primary immunization. Serum antibody responses were not seen in any of the vaccines after secondary immunization, whereas after primary immunization 60% of these subjects responded. This study shows the presence of immunologic memory also in respect of the human ASC response, and confirms the separate nature of ASC and serum responses.
引用
收藏
页码:423 / 427
页数:5
相关论文
共 50 条
  • [21] INTRODUCTION OF SHIGELLA-FLEXNERI 2A-TYPE AND GROUP ANTIGEN GENES INTO ORAL TYPHOID VACCINE STRAIN SALMONELLA-TYPHI TY21A
    BARON, LS
    KOPECKO, DJ
    FORMAL, SB
    SEID, R
    GUERRY, P
    POWELL, C
    INFECTION AND IMMUNITY, 1987, 55 (11) : 2797 - 2801
  • [22] GENETIC-CHARACTERISTICS OF THE SALMONELLA-TYPHI STRAIN-TY21A VACCINE
    SILVA, BA
    GONZALEZ, C
    MORA, GC
    CABELLO, F
    JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (05): : 1077 - 1078
  • [23] EFFICACY OF ONE OR 2 DOSES OF TY21A SALMONELLA-TYPHI VACCINE IN ENTERIC-COATED CAPSULES IN A CONTROLLED FIELD TRIAL
    BLACK, RE
    LEVINE, MM
    FERRECCIO, C
    CLEMENTS, ML
    LANATA, C
    ROONEY, J
    GERMANIER, R
    VACCINE, 1990, 8 (01) : 81 - 84
  • [24] Genetic stability of vaccine strain Salmonella Typhi Ty21a over 25 years
    Kopecko, Dennis J.
    Sieber, Heike
    Ures, Jose A.
    Fuerer, Andreas
    Schlup, Jacqueline
    Knof, Ulrich
    Collioud, Andre
    Xu, DeQi
    Colburn, Kevin
    Dietrich, Guido
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 299 (04) : 233 - 246
  • [25] Development of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery
    Dharmasena, Madushini N.
    Feuille, Catherine M.
    Starke, Carly Elizabeth C.
    Bhagwat, Arvind A.
    Stibitz, Scott
    Kopecko, Dennis J.
    PLOS ONE, 2016, 11 (09):
  • [26] EFFICACY OF LIVE ORAL TYPHOID VACCINE (SALMONELLA-TYPHI TY-21A) IN VOLUNTEER STUDIES AND FIELD TRIALS
    CRYZ, SJ
    FURER, E
    LEVINE, MM
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 118 (13) : 467 - 470
  • [27] IMPAIRMENT OF IMMUNOGENICITY OF SALMONELLA-TYPHI TY21A DUE TO PREEXISTING CROSS-REACTING INTESTINAL ANTIBODIES
    FORREST, BD
    JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (01): : 210 - 212
  • [28] The rpoS mutant allele of Salmonella typhi Ty2 is identical to that of the live typhoid vaccine Ty21a
    Robbe-Saule, V
    Norel, F
    FEMS MICROBIOLOGY LETTERS, 1999, 170 (01) : 141 - 143
  • [29] ORAL IMMUNIZATION AGAINST TYPHOID-FEVER IN INDONESIA WITH TY21A VACCINE
    SIMANJUNTAK, CH
    PALEOLOGO, FP
    PUNJABI, NH
    DARMOWIGOTO, R
    TOTOSUDIRJO, SH
    HARYANTO, P
    SUPRIJANTO, E
    WITHAM, ND
    HOFFMAN, SL
    LANCET, 1991, 338 (8774): : 1055 - 1059
  • [30] Local and systemic immune responses to combined Vibrio cholerae CVD103-HgR and Salmonella typhi Ty21a live oral vaccines after primary immunization and reimmunization
    Kollaritsch, H
    Cryz, SJ
    Lang, AB
    Herzog, C
    Que, JU
    Wiedermann, G
    VACCINE, 2000, 18 (26) : 3031 - 3039